CompanyCompetitive AnalysisCompany Patent Opposition Analysis

Explore Shire Viropharma Incorporated's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 7, 2025
Patent NumberGrant DateTitleTotal Oppositions
Nov 14, 2018Methods Of Treating Antibody-Mediated Rejection In Organ Transplant Patients With C1-Esterase Inhibitor1
Jun 28, 2017C1-Inh Compositions And Methods For The Prevention And Treatment Of Disorders Associated With C1 Esterase Inhibitor Deficency2

Top competitors of Shire Viropharma Incorporated

List of top competitors of Shire Viropharma Incorporated based on patent oppositions.